CD274 and breast cancer: Moreover, anti-PD-1/PD-L1 antibody, anti-CTLA-4 antibody, anti-LAG-3 antibody, and other immune checkpoint inhibitor can inhibit tumor escape, thereby providing a new strategy for the treatment of BC (8–10).